NCT00744302View on ClinicalTrials.gov

Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.

PHASE2CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

HyperparathyroidismHypercalcemia

Interventions

DRUG

physiological (1.25 mmol/L ) calcium dialysate

Using the physiological calcium dialysate (1.25 mmol/L calcium dialysate)for Stable haemodialysis treatment for more than 3 months, undergoing 2 to 3 times haemodialysis a week for 4 to 5 hours per session

Trial Locations (1)

510080

The 1st Affiliated Hospital, Sun Yet-sen University, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT00744302 - Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients. | Biotech Hunter | Biotech Hunter